TL;DRAbstract
Non-Hodgkin lymphoma (NHL) is a heterogeneous cancer encompassing several dozen distinct clinicopathologic diseases. The incidence of NHL appears to be rising independent of the aging of the population, and NHL currently ranks as the fifth most common cancer in both men and women with 71,380 new cases in 2007 and nearly 20,000 estimated deaths. Diffuse large B-cell lymphoma (DLBCL), accounting for approximately one-third of all new cases, is both the most common histologic subtype of NHL and the prototype of aggressive lymphomas.
Chat with Paper
AI Agents for this Paper
Non-Hodgkin lymphoma (NHL) is a heterogeneous cancer encompassing several dozen distinct clinicopathologic diseases. The incidence of NHL appears to be rising independent of the aging of the population, and NHL currently ranks as the fifth most common cancer in both men and women with 71,380 new cases in 2007 and nearly 20,000 estimated deaths. Diffuse large B-cell lymphoma (DLBCL), accounting for approximately one-third of all new cases, is both the most common histologic subtype of NHL and the prototype of aggressive lymphomas.
Keywords
Chat
Click to start Chat